Osteotech Tissue Recall Traced To Equipment Malfunction In Electrical Storm
This article was originally published in The Gray Sheet
Executive Summary
Osteotech is testing the rework procedure it developed to resterilize recalled and quarantined donor tissue and hopes to have the procedure validated and in place by year-end
You may also be interested in...
CDRH Examining CryoLife Heart Valve Risks Following Tissue Recall
CDRH is reviewing potential risks associated with CryoValve heart valves in the wake of an Aug. 14 recall order for CryoLife human tissue products
FDA Tissue Registration Rule Clarifies Classification Of Combination Devices
Manufacturers of combination devices incorporating human cells or tissues will have until Jan. 19, 2003 to register with FDA, according to a final rule released by the agency Jan. 18.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”